I live in a democracy. But as Thanksgiving approaches, I find myself longing for the type of freedom I am seeing in China.
Nov 23, 2020
1
3
The availability of adequate health care facilities is one of the most important factors that public-health policymakers grapple with when preparing for infectious disease outbreaks such as COVID-19.
Nov 23, 2020
0
2
The United States on Tuesday registered a record 200,000 new COVID-19 cases in one day, highlighting the desperate need for a vaccine after results from one medical trial fuelled optimism around the world.
Nov 10, 2020
0
0
The economy and coronavirus pandemic were two of the top issues for voters in the 2020 election, according to exit poll surveys. Notably, 52% of voters said controlling the pandemic was more important, even if it hurts the ...
Nov 9, 2020
0
28
As temperatures fall, honey's popularity tends to rise. Whether used as an ingredient in autumn recipes and holiday desserts, added to a celebratory cocktail or given to ease a child's cough, it certainly satisfies a sweet ...
Nov 6, 2020
0
3
Swiss authorities said Tuesday they had begun assessing AstraZeneca and Oxford University's COVID-19 vaccine—the first such treatment submitted for authorisation in the country.
Oct 6, 2020
0
5
European regulators are evaluating early data from a coronavirus vaccine being developed by Germany's BioNTech and US giant Pfizer, the firms said Tuesday, under a fast-track procedure aimed at speeding up the approvals process.
Oct 6, 2020
0
1
A Chinese company is entering the global race to help defeat the coronavirus, promising its testing machine will return results faster than a lab and more reliably than at-home screening kits.
Sep 29, 2020
0
2
China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.
Sep 7, 2020
0
8
With the race on to find a coronavirus vaccine, the biotech sector—from an investor's point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the exuberance could be exaggerated.
Aug 18, 2020
0
3
